Assuntos
Proteínas de Bactérias/genética , Farmacorresistência Bacteriana/genética , Klebsiella pneumoniae/genética , Rifampina/farmacologia , beta-Lactamases/genética , Antibióticos Antituberculose/farmacologia , Sequência de Bases , DNA Bacteriano/análise , Klebsiella pneumoniae/efeitos dos fármacos , Dados de Sequência Molecular , Família Multigênica , Plasmídeos/genéticaRESUMO
Ochrobactrum anthropi, formerly known as CDC group Vd, is an oxidase-producing, gram-negative, obligately aerobic, non-lactose-fermenting bacillus of low virulence that occasionally causes human infections. It is highly resistant to all beta-lactams except imipenem. A clinical isolate, SLO74, and six reference strains were tested. MICs of penicillins, aztreonam, and most cephalosporins tested, including cefotaxime and ceftazidime, were >128 microg/ml and of cefepime were 64 to >128 microg/ml. Clavulanic acid was ineffective and tazobactam had a weak effect in association with piperacillin. Two genes, ampR and ampC, were cloned by inserting restriction fragments of genomic DNA from the clinical strain O. anthropi SLO74 into pBK-CMV to give the recombinant plasmid pBK-OA1. The pattern of resistance to beta-lactams of this clone was similar to that of the parental strain, except for its resistance to cefepime (MIC, 0.5 ,micro/ml). The deduced amino acid sequence of the AmpC beta-lactamase (pI, 8.9) was only 41 to 52% identical to the sequence of other chromosomally encoded and plasmid-encoded class C beta-lactamases. The kinetic properties of this beta-lactamase were typical for this class of beta-lactamases. Upstream from the ampC gene, the ampR gene encodes a protein with a sequence that is 46 to 62% identical to those of other AmpR proteins and with an amino-terminal DNA-binding domain typical of transcriptional activators of the Lys-R family. The deduced amino acid sequences of the ampC genes of the six reference strains were 96 to 99% identical to the sequence of the clinical strain. The beta-lactamase characterized from strain SLO74 was named OCH-1 (gene, bla(OCH-I)).
Assuntos
Proteínas de Bactérias/genética , Cromossomos Bacterianos/genética , Ochrobactrum anthropi/enzimologia , beta-Lactamases/genética , Sequência de Aminoácidos , Antibacterianos/farmacologia , Proteínas de Bactérias/metabolismo , Sequência de Bases , Cromossomos , Primers do DNA/química , Resistência a Múltiplos Medicamentos/genética , Focalização Isoelétrica , Testes de Sensibilidade Microbiana , Dados de Sequência Molecular , Ochrobactrum anthropi/genética , Filogenia , Reação em Cadeia da Polimerase , Homologia de Sequência de Aminoácidos , beta-Lactamases/metabolismo , beta-LactamasRESUMO
Fifty-two strains of Klebsiella pneumoniae producing an AmpC-type plasmid-mediated beta-lactamase were isolated from 13 patients in the same intensive care unit between March 1998 and February 1999. These strains were resistant to ceftazidime, cefotaxime and ceftriaxone, but susceptible to cefoxitin, cefepime and aztreonam. Plasmid content and genomic DNA restriction pattern analysis suggested dissemination of a single clone. Two beta-lactamases were identified, TEM-1 and ACC-1. We used internal bla(ACC-1) primers, to sequence PCR products obtained from two unrelated strains of Hafnia alvei. Our results show that the ACC-1 beta-lactamase was derived from the chromosome-encoded AmpC-type enzyme of H. alvei.
